BioSpace News Archive

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third quarter ended September 30, 2020.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today announced the funding and initiation of an open-label exploratory trial evaluating the antiviral effects of voclosporin in kidney transplant recipients (KTRs) with COVID-19 (SARS-CoV-2) – the VOCOVID study.

Masimo (Nasdaq: MASI) today announced its financial results for the third quarter ended September 26, 2020

Consolidated gross margin up 260 basis points to 27.6% driven by impressive Service segment gross margin of 32.2% Total revenue of $41.6 million consistent with prior-year period in a challenging market environment; Service segment achieved 46 th consecutive quarter of year-over-year growth Quarterly cash from operations of $8.5 million; debt reduced by $5.8 million

The United States Preventive Services Task Force (USPSTF) today released draft updated colorectal cancer screening guidelines recommending that screening begin at age 45, and including Exact Sciences’ (NASDAQ: EXAS) Cologuard® (referred to in the draft guidelines as sDNA-FIT) as a recommended screening method for all average-risk patients between the ages of 45 and 75.

HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) plans to release its complete financial results for the quarter and fiscal year ended July 31, 2020, after market hours on Thursday, October 29, 2020, as well as host a webcast for investors and analysts beginning at 8:30 a.m. EDT on Friday October 30, 2020.

Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2020 results.

Most medical practices have remained open during the threat of Covid-19 and many are dispensing medication directly to patients at the point of care instead of sending them to the pharmacy (physician dispensing).

The new registration follows launch announcement for XtendFlex® soybeans and enables full potential of industry-leading Roundup Ready® Xtend Crop System

Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the consumer level.